1. Secilmis S, Sinan Dal M, Kizil Cakar M, Merdin A, Ahu Baysal N, Altuntas F. Combination of Venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia: A case series from a single center. J BUON. 2021 Sep-Oct;26(5):2026-2032.

2. Aslan Candır B, Yiğenoğlu TN, Kızıl Çakar M, Dal MS, Altuntaş F. Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities. J Oncol Pharm Pract. 2022 Jan 10:10781552211073885. doi: 10.1177/10781552211073885.

3. Aslan Candır B, Yiğenoğlu TN, Kızıl Çakar M, Dal MS, Altuntaş F. Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease. J Oncol Pharm Pract. 2022 Jan 12:10781552211073881. doi: 10.1177/10781552211073881.

4. Dicle İskender, Seval Yılmaz-Ergani, Munevver Aksoy, Betul Tokgoz, Mujde Can Ibanoglu, Merih Kızıl Çakar, Turhan Caglar, Fevzi Altuntas. High Rate of Obstetric Complications in Patients With Essential Thrombocythemia. Cureus 13(12): e20449. doi:10.7759/cureus.20449.

5. Alparslan Merdin, Mehmet Sinan Dal, Merih Kizil Çakar, Taha Bahsi, Neslihan Düzkale, Jale Yildiz, Mehmet Bakirtaş, Semih Başçi, Tahir Darçin, Derya Şahin, Ayşegül Tetik, Bahar Uncu Ulu, Dicle İskender, Tuğçe Nur Yiğenoğlu, Fevzi Altuntaş. Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study. Medicine 2021;100 (41): e27458.

6. Pagano L, Salmanton-García J; EPICOVIDEHA working group. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0.

7. Samet Yaman, Semih Başcı, Gökhan Turan Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Single-Dose Rasburicase Might Be Adequate to Overcome Tumor Lysis Syndrome In Hematological Malignancies. Clin Lymphoma Myeloma Leuk. 2021 Aug 28:S2152-2650(21)02012-7. doi: 10.1016/j.clml.2021.08.009.

8. Sinan Dal M, Merdin A, Erkurt MA, Ekinci Ö, Albayrak M, Kabukcu Hacıoglu S, Kaya A, Dogu MH, Hindilerden F, Sarici A, Merter M, Reis Aras M, Akgun Caglıyan G, Kizil Cakar M, Aydogdu I, Kuku I, Korkmaz S, Ulas T, Eser B, Altuntas F. Pralatrexate experience in PTCL: A multicenter retrospective study from Turkey. J BUON. 2021 Jul-Aug;26(4):1536-1539.

9. Mert D, Merdin A, Ceken S, Dal MS, Ertek M, Altuntas F. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma. J Cancer Res Ther. 2021 Jul-Sep;17(4):951-955.

10. Uncu Ulu B, Dal MS, Yönal Hindilerden İ, Akay OM, Mehtap Ö, Büyükkurt N, Hindilerden F, Güneş AK, Yiğenoğlu TN, Başcı S, Kızıl Çakar M, Yanardağ Açık D, Korkmaz S, Ulaş T, Özet G, Ferhanoğlu B, Nalçacı M, Altuntaş F. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. J Chemother. 2021 Sep 13:1-9. doi: 10.1080/1120009X.2021.1976912.

11. Ulu BU, Yiğenoğlu TN, Başcı S, Bakırtaş M, Şahin D, Darçın T, Yaman S, Bozan E, Seçilmiş S, Candır BA, Yıldız J, İskender D, Baysal NA, Çakar MK, Dal MS, Altuntaş F. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma. Leuk Res. 2021 Aug 28;110:106700. doi: 10.1016/j.leukres.2021.106700.

12. Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Derya Şahin, Semih Başcı, Dicle İskender, Yasemin Adaş, Ebru Atasever Akkaş, Tuba Hacıbekiroğlu, Merih Kızıl çakar, Mehmet Sinan DAL, Fevzi Altuntaş. Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation? Cureus 13(11): e19462. doi:10.7759/cureus.19462.

13. Kalpakci Y, Hacibekiroglu T, Darcin T, AkgunCagliyan G, Cakar MK, Hacioglu SK, Ekinci O, Korkmaz S, Albayrak M, Dal MS, Dogan A, Ulas T, Eser B, Altuntas F. Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey. Transfus Apher Sci. 2021 Oct;60(5):103244. doi: 10.1016/j.transci.2021.103244.

14. Batgi H, Dal MS, Erkurt MA, Kuku I, Kurtoglu E, Hindilerden IY, Kaya E, Berber I, Ulas T, Altuntas F. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience. Transfus Apher Sci. 2021 Oct;60(5):103242. doi: 10.1016/j.transci.2021.103242.

15. Dal MS, Batgi H, Erkurt MA, Hindilerden IY, Kuku I, Kurtoglu E, Kaya E, Besisik SK, Berber I, Nalcaci M, Ulas T, Altuntas F. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study. Transfus Apher Sci. 2021 Oct;60(5):103243. doi: 10.1016/j.transci.2021.103243.

16. Basturk A, Sayin S, Erkurt MA, Sarici A, Ekinci O, Kum A, Berber I, Korkmaz S, Dogan A, Ulas T, Kuku I, Eser B, Altuntas F. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura. Transfus Apher Sci. 2021 Oct;60(5):103246. doi: 10.1016/j.transci.2021.103246.

17. Başcı S, Yiğenoğlu TN, Yaman S, Bozan E, Ulu BU, Bakırtaş M, Kılınç A, Özcan N, Bahsi T, Dal MS, Çakar MK, Altuntaş F. Does myeloma genetic have an effect on stem cell mobilization? Transfus Apher Sci. 2021 Aug 17:103249. doi: 10.1016/j.transci.2021.103249.

18. Yiğenoğlu TN, Başcı S, Şahin D, Ulaş T, Dal MS, Korkmaz S, Hacıbekiroğlu T, Namdaroğlu S, Erkurt MA, Turgut B, Altuntaş F. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021 Aug 17:103237. doi: 10.1016/j.transci.2021.103237.

19. Aydin K, Korkmaz S, Erkurt MA, Sarici A, Ekinci O, Baysal NA, Berber I, Dogan A, Dal MS, Giden AO, Ulas T, Kuku I, Ozatli D, Eser B, Altuntas F. Apheresis in patients with sepsis: A multicenter retrospective study. Transfus Apher Sci. 2021 Oct;60(5):103239. doi: 10.1016/j.transci.2021.103239.

20. Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122.

21. Akay OM, Ozbalak M, Pehlivan M, Yildiz B, Uzay A, Yigenoglu TN, Elverdi T, Kaynar L, Ayyildiz O, Yonal Hindilerden I, Goksoy HS, Izmir Guner S, Gunes AK, Sonmez M, Kurt Yuksel M, Civriz Bozdag S, Ozkurt ZN, Toptas T, Dogu MH, Salim O, Saydam G, Yavasoglu I, Ayli M, Ozet G, Albayrak M, Birtas Atesoglu E, Toprak SK, Yildirim R, Mehtap O, Kalayoglu Besisik S, Nalcaci M, Altuntas F, Ferhanoglu B. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study. Hematol Oncol. 2021 Jun 25. doi: 10.1002/hon.2897.

22. Jale Yıldız, Mehmet Sinan Dal, Merih Kızıl Çakar, Tuğçe Nur Yiğenoğlu, Alparslan Merdin, Dicle İskender, Nuran Ahu Baysal, Hikmetullah Batgi, Derya Şahin, Mehmet Bakırtaş, Tahir Darçın, Semih Başçı, Bahar Uncu Ulu, Fevzi Altuntaş. Return to Work of Lymphoma Survivors After Autologous Stem Cell Transplantation: A Single-Center Cross-Sectional Study. Iranian Red Crescent Medical Journal,23(7) . https://doi.org/10.32592/ircmj.2021.23.7.644.

23. Akpinar, S., Dogu, M. H., Celik, S., Ekinci, O., Hindilerden, I. Y., Dal, M. S., ... & Altuntas, F. (2021). THE REAL WORLD EXPERIENCE WITH SINGLE AGENT IBRUTINIB IN RELAPSED/REFRACTORY CLL. Clinical Lymphoma Myeloma and Leukemia. 2021. https://doi.org/10.1016/j.clml.2021.09.010.

24. Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med. 2021 Jun 10. doi: 10.1007/s11739-021-02784-y.

25. Yildiz J, Ulu BU, Yiğenoğlu TN, Başçı S, Darçın T, Bakırtaş M, Şahin D, Batgi H, Merdin A, Baysal NA, İskender D, Çakar MK, Dal MS, Altuntaş F. Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study. Eur Rev Med Pharmacol Sci. 2021 May;25(10):3655-3660. doi: 10.26355/eurrev_202105_25931.

26. Goren Sahin D, Akay OM, Keklik M, Okan V, Karakus A, Demir C, Erkurt MA, Ilkkilic K, Yildirim R, Akgun Cagliyan G, Aksu S, Dogu MH, Dal MS, Karakus V, Gemici AI, Terzi H, Kelkitli E, Sivgin S, Unal A, Yilmaz M, Ayyildiz O, Korkmaz S, Eser B, Altuntas F. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience. Ann Hematol. 2021 May 14. doi: 10.1007/s00277-021-04554-4.

27. Batgi H, Başçı S, Bakırtaş M, Ulu BU, Yiğenoğlu TN, Yildiz J, İskender D, Özcan N, Dal MS, Çakar MK, Altuntaş F. Effect of the Amount of Autologous Hematopoietic Stem Cells on Survival and Engraftment in Multiple Myeloma. Iranian Red Crescent Medical Journal, 23(5). Retrieved from https://ircmj.org/index. php/ IRCMJ/ article/ view/613.

28. Uncu Ulu B, Yiğenoğlu TN, Hacıbekiroğlu T, Sağlam DA, Kılınç A, İskender G, Çakar MK, Dal MS, Altuntaş F. Recovery of Symmetrical Peripheral Gangrene of Limbs in a Patient After Performing Hemoadsorption in Septic Shock. J Clin Apher. 2021 Mar 23. doi: 10.1002/jca.21893.

29. Başcı S, Yiğenoğlu TN, Bakırtaş M, Uncu Ulu B, Yaman S, Dal MS, Kızıl Çakar M, Altuntaş F. The effect of bulky mass on prognosis in diffuse large-B-cell lymphoma: still poor? Leuk Res. 2021 Mar; 102:106521. doi: 10.1016/j.leukres.2021.106521.

30. Başcı S, Bakırtaş M, Yiğenoğlu TN, Uncu Ulu B, Batgi H, Yıldız J, Dal MS, Kızıl Çakar M, Altuntaş F. The Outcome of Diffuse Large B Cell Lymphoma Patients in Adolescent and Young Adult Age Group. J Adolesc Young Adult Oncol. 2020 Nov 25. doi: 10.1089/jayao.2020.0145.

31. Batgi H, Başci S, Dal MS, Kizil Çakar M, Uncu Ulu B, Yiğenoğlu TN, Özcan N, Kilinç A, Merdin A, Yildiz J, Bakirtaş M, Şahin D, Darçin T, İskender D, Baysal NA, Altuntaş F. Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience. Turk J Med Sci. 2020 Nov 25. doi: 10.3906/sag-2008-114.

32. Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Semih Başcı, Mehmet Bakırtaş, Derya Şahin, Tahir Darçın, Jale Yıldız, Alparslan Merdin, Nuran Ahu Baysal, Dicle İskender, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Autologous Stem Cell Transplantation in Multiple Myeloma Patients Over 60 Years Old. Medical Laboratory Technology Journal 2021. DOI: 10.31964/mltj.v0i0.280

33. Dal MS, Ata N, Altuntaş F, Başci S, Yiğenoğlu TN, Korkmaz S, Namdaroğlu S, Baştürk A, Hacibekiroğlu T, Doğu MH, Berber I, Dal K, Erkurt MA, Turgut B, Çağlayan M, Imrat E, Çelik O, Ülgü MM, Birinci Ş. Covid-19 Clinical Course and Blood Groups: Turkish Population-Based Study. Turk J Med Sci. 2021 May 7. doi: 10.3906/sag-2101-321.

34. Semih Başcı, Mehmet Bakırtaş, Bahar Uncu Ulu, Tuğçe Nur Yigenoğlu, Samet Yaman, Hikmetullah Batgi, Ali Kılınç, Nurgül Özcan, Derya Sahin, Jale Yildiz, Dicle Iskender, Nuran Ahu Baysal, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Old is bad? The effect of age on perıpheral stem cell mobilizatıon and transplantation outcomes. Transfus Apher Sci. 2020. DOI:https://doi.org/10.1016/ j.transci.2020. 103007.

35. Jale Yildiz, Mehmet Sinan Dal,Tugçe Nur Yigenoglu, Hikmetullah Batgi, Bahar Uncu Ulu, Tahir Darçin, Mehmet Bakirtas, Derya Sahin, Alparslan Merdin, Sema Seçilmis, Semih Basçi, Nuran Ahu Baysal, Dicle Iskender, Merih Kizil Çakar, Fevzi Altuntas. Return to Work in Lymphoma Survivors After Autologous Stem Cell Transplantation: A Single Center Cross-Sectional Study. JNMA 2020.

36. Mert D, Merdin A, Ceken S, Dal MS, Ertek M, Altuntas F. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma. J Can Res Ther 2020. DOI: 10.4103/jcrt.JCRT_465_19.

37. Fevzi Altuntaş, Tuğçe Nur Yigenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Burhan Turgut, Mehmet Ali Erkut. Mesenchymal Stem Cell Therapy in Patients with COVID-19. Transfus Apher Sci. 2021.

38. Semih Başcı, Naim Ata, Fevzi Altuntaş, Tuğçe Nur Yigenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Abdulkadir Baştürk, Tuba Hacıbekiroglu, Mehmet Hilmi Doğu, İlhami Berber, Kürşad Dal, Mehmet Ali Erkurt, Burhan Turgut, Murat Caglayan, Mustafa Okan Ayvalı, Osman Çelik, Mustafa Mahir Ulgu, Şuayip Birinci. On Behalf of Turkish Ministry of Health, Hematology Scientific Working Group. Patients With Hematological Malignancies Are More Vulnerable to COVID-19 Compared to Patients With Solid Tumors. Annals of Oncology 2020.

39. Fevzi Altuntaş, Naim Ata, Tugce Nur Yigenoglu, Semih Başcı, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Abdulkadir Baştürk, Tuba Hacıbekiroglu, Mehmet Hilmi Doğu, İlhami Berber, Kürşat Dal, Mehmet Ali Erkurt, Burhan Turgut, Mahir İlgü, Osman Çelik, Ersan İmrat, Şuayip Birinci. On Behalf of Turkish Ministry of Health, Hematology Scientific Working Group. COVID-19 in Hematopoietic Cell Transplant Recipients. Bone Marrow Transplant. 2020 Oct 28. doi: 10.1038/s41409-020-01084-x.

40. Altuntaş F, Ata N, Yiğenoğlu TN, Başcı S, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Kınık K, Haznedaroglu I, FM Yılmaz, Kılıç I, Demircioğlu S, Yosunkaya A, Erkurt MA, Turgut B, Çağlayan M, Çelik O. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2020 Sep 19:102955. doi: 10.1016/j.transci.2020.102955.

41. Ceken S, Gedik H, Iskender G, Demirelli M, Mert D, Yapar Toros G, Yigenoglu TN, Altuntas F, Oksuzoglu B, Ertek M. Evaluation of Risk Factors fr Mortality in Febrile Neutropenia. J Infect Dev Ctries. 2020 Aug 31;14(8):886-892. doi: 10.3855/jidc.12520.

42. Yildiz F, Durnali A, Eraslan E, Ilhan A, Tufan G, Aslan F, Arslan UY, Alkis N, Demirci U, Altuntas F, Oksuzoglu B. Outcomes of Autologous Stem Cell Transplantation (ASCT) in Relapsed/Refractory Germ Cell Tumors: Single Center Experience from Turkey. Urol J. 2020 Aug 25. doi: 10.22037/uj.v16i7.6004.

43. Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Ayvalı MO, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Aug 27:1078155220953198. doi: 10.1177/1078155220953198.

44. Mert D, Merdin A, Çakar MK, Dal MS, Altuntaş F. Evaluation of HBV, HCV, and HIV seroprevalence in patients with plasma cell disorders. Medicine (Baltimore). 2020 Aug 21;99(34):e21799. doi: 10.1097/MD.0000000000021799.

45. Yigenoglu TN, Ata N, Altuntas F, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S. The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2020 Aug 10:10.1002/jmv.26404. doi: 10.1002/jmv.26404.

46. Yiğenoğlu TN, Hacıbekiroğlu T, Berber İ, Dal MS, Baştürk A, Namdaroğlu S, Korkmaz S, Ulas T, Dal T, Erkurt MA, Turgut B, Altuntaş F. Convalescent Plasma Therapy in Patients with COVID-19. J Clin Apher. 2020 Aug;35(4):367-373. doi: 10.1002/jca.21806.

47. Yiğenoğlu TN, Ulas T, Dal MS, Korkmaz S, Erkurt MA, Altuntaş F. Extracorporeal Blood Purification Treatment Options for COVID-19: The Role of Immunoadsorption. Transfus Apher Sci. 2020 Aug;59(4):102855. doi: 10.1016/j.transci.2020.102855.

48. Nur Soyer, Mehmet Gunduz, Emre Tekgunduz, Burak Deveci, Hakan Ozdogu, Handan Haydaroglu Sahin, Esra Ermis Turak, Mufide Okay, Irfan Kuku, Ipek Yonal Hindilerden, Pervin Topcuoglu, Fevzi Altuntas, Ihsan Karadogan, Mustafa Pehlivan, Ali Unal, Hakan Goker, Mehmet Ali Erkurt, Sevgi Kalayoglu Besısık, Filiz Vural. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of Turkish Hematology Research and Education Group (ThREG). Transfus Apher Sci. 2020 Aug;59(4):102827. doi: 10.1016/j.transci.2020.102827.

49. Bekoz H, Ozbalak M, Karadurmus N, Paydas S, Turker A, Toptas T, Tuglular TF, Altuntas F, Cakar MK, Sonmez M, Gulbas Z, Demir N, Kaynar L, Yildirim R, Karadogan I, Arat M, Kapucu I, Aslan NA, Ozkocaman V, Turgut M, Yuksel MK, Ozcan M, Hacioglu SK, Barista I, Demirkaya M, Saydam G, Toprak SK, Yilmaz M, Demirkol O, Ferhanoglu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. Ann Hematol. 2020 Jun 7. doi: 10.1007/s00277-020-04077-4.

50. Alparslan Merdin, Mehmet Sinan Dal, Merih Kizil Çakar, Jale Yildiz, Bahar Uncu Ulu, Hikmetullah Batgi, Aysegül Tetik, Sema Seçilmis, Tahir Darçin, Derya Sahin, Mehmet Bakirtas, Semih Basçi, Tugçe Nur Yigenoglu, Nuran Ahu Baysal, Dicle Iskender, Fevzi Altuntas. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations. Medicine 99 (14): e19627.

51. Batgi H, Merdin A, Sinan Dal M, Kızıl Çakar M, Yıldız J, Başçı S, Uncu Ulu B, Yiğenoğlu TN, Darçın T, Şahin D, Bakırtaş M, Tetik A, İskender D, Altuntaş F. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience. J Oncol Pharm Pract. 2020 Feb 25:1078155220905654. doi: 10.1177/1078155220905654.

52. Büyükaşık Y, Ali R, Turgut M, Saydam G, Yavuz S, Ünal A, Ar MC, Ayyıldız O, Altuntaş F, Okay M, Çiftçiler R, Meletli Ö, Soyer N, Mastanzade M, Güven Z, Soysal T, Karakuş A, Yiğenoğlu TN, Uçar B, Gökçen E, Tuğlular T. Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythaemia Vera: a Multicentre Chart Review Study. Turk J Haematol. 2020 Feb 20. doi: 10.4274/tjh.galenos.2020.2019.0431.

53. Mert D, Ceken S, Iskender G, Iskender D, Merdin A, Duygu F, Ertek M, Altuntas F. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. J Infect Dev Ctries. 2019 Aug 31;13(8):727-735. doi: 10.3855/jidc.11457.

54. Batgi H, Sinan Dal M, Merdin A, Kızıl Çakar M, Yiğenoğlu TN, Altuntaş F. A multiple myeloma patient who developed ischemic colitis during lenalidomide treatment: A rare case report. J Oncol Pharm Pract. 2020 Feb 6:1078155219900910. doi: 10.1177/1078155219900910.

55. Tuğçe Nur Yiğenoğlu, Semih Başcı, Bahar Uncu Ulu, Mehmet Bakırtaş, Ali Kılınç, Tahir Darçın, Jale Yıldız, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş. Inferior prognosis in poor mobilizing myeloma patients. Transfus Apher Sci. 2020 Jun;59(3):102722. doi: 10.1016/j.transci.2020.102722.

56. Tuğçe Nur Yiğenoğlu, Semih Başcı, Mehmet Bakırtaş, Bahar Uncu Ulu, Ali Kılınç, Derya Şahin, Tahir Darçın, Jale Yıldız, Alparslan Merdin, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş. The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors. Transfus Apher Sci. 2020 Jun;59(3):102726. doi: 10.1016/j.transci.2020.102726.

57. Merdin A, Çakar MK, Dal MS, Mert D, Yıldız J, Başçı S, Bakırtaş M, Darçın T, Şahin D, Ulu BU, Yiğenoğlu TN, Batgi H, Tetik A, İskender D, Altuntaş F. Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor. J Oncol Pharm Pract. 2020 Jun;26(4):929-932. doi: 10.1177/1078155219891663.

58. Mert D, Merdin A, Ceken S, Sinan Dal M, Ertek M, Altuntas F. Development of pneumonitis after rituximab treatment in a patient with lymphoma.J Oncol Pharm Pract. 2020 Jun;26(4):1009-1010. doi: 10.1177/1078155219879496.

59. Okay M, Aslan T, Ozdemir E, Uner A, Saglam A, Gungor E, Uysal A, Alayvaz Aslan N, Yildizhan E, Agit A, Dal MS, Korkmaz S, Namdaroglu S, Sivgin S, Akgun Cagliyan G, Demircioglu S, Barista I, Ozhamam E, Vural F, Eser B, Ozet G, Yildirim R, Dogu MH, Berber I, Erkurt MA, Malkan UY, Altuntas F, Buyukasik Y. Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study. Turk J Haematol. 2020 May 6;37(2):84-90. doi: 10.4274/tjh.galenos.2019.2019.0177.

60. Tuğçe Nur Yigenoğlu, Mehmet Bakırtaş, Semih Başcı, Bahar Uncu Ulu, Derya Şahin, Ali Kılınç, Fatma Nurbüke Şarkışla, Dicle İskender, Nurgül Özcan, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş. Blood group A is a negative risk factor for peripheric blood stem cell mobilization in allogeneic donors. Medical Science and Discovery 2020;7(6):505-508. https://doi.org/ 10.36472/msd.v7i6.382.

61. Olga Meltem Akay; Murat Ozbalak; Birol Yıldız; Mustafa Pehlivan; Tuğçe Nur Yiğenoğlu; Ant Uzay; İpek Yönal Hindilerden; Hasan Sami Göksoy; Şebnem İzmir Güner; Ahmet Kürşad Güneş; Mehmet Sonmez; Meltem Kurt Yüksel; Orhan Ayyıldız; Leylagül Kaynar; Mehmet Hilmi Doğu; Tuğrul Elverdi; Ozan Salim; Güray Saydam; İrfan Yavaşoğlu; Meltem Aylı; Gülsüm Özet; Tayfur Toptaş; Murat Albayrak; Elif Birtaş Ateşoğlu; Zübeyde Nur Özkurt; Selami K Toprak; Rahşan Yıldırım; Meliha Nalçacı; Fevzi Altuntaş; Burhan Ferhanoğlu. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin’s Lymphoma: Multi-Center Real-Life Experience. International Journal of Clinical Oncology 2020.

62. Başcı S, Yiğenoğlu T.N., Bakırtaş M., Ulu B. U., Şahin D., Darçın T., Yıldız J., İskender D., Baysal N. A., Dal M. S., Çakar M. K., & Altuntaş F. (2020). Bone marrow plasma cell ratio, is it must to evaluate before autologous stem cell transplantation in multiple myeloma? Medical Science and Discovery, 7(4), 470-474. https://doi.org/10.36472/msd.v7i4.372.

63. Semih Başcı, Tuğçe Nur Yiğenoğlu, Bahar Uncu Ulu, Mehmet Bakırtaş, Derya Şahin, Tahir Darçın, Jale Yıldız, Alparslan Merdin, Nuran Ahu Baysal, Dicle İskender, Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş. Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents. Medical Laboratory Technology Journal 2020. DOI: 10.31964/mltj.v0i0.281.

64. Bahsi T, Yigenoglu TN, Erdem HB, Çakar MK, Dal MS, Altuntas F. Evaluation of Clinical Outcome and Mixed Chimerism Follow-up after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies. Gazi Medical Journal 31:52-55. DOI: 10.12996/gmj.2020.13.

65. Mehmet Bakırtaş, Tuğçe Nur Yiğenoğlu, Semih Başcı, Bahar Uncu Ulu, Nurgül Özcan, Dicle İskender, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş. Second Allogeneic Stem Cell Transplantation in Acute Leukemia Patients: Single Center Experience. Jurnal Teknologi Laboratorium, 2020. doi.org/10.29238/teknolabjournal.v9i1.208.

66. Mehmet Bakirtas, Tugce Nur Yigenoglu, Semih Basci, Bahar Uncu Ulu, Nurgul Ozcan, Merih Kizil Cakar, Mehmet Sinan Dal, Fevzi Altuntas. Outcome of allogeneic stem cell transplantation with active disease in acute myeloid leukemia. Sanamed 2020; 15(1): 15–19. DOI: 10.24125/sanamed.v15i1.397.

67. Tuğçe Nur Yiğenoğlu, Derya Şahin, Semih Başcı, Mehmet Bakırtaş, Tahir Darçın, Jale Yıldız, Bahar Uncu Ulu, Dicle İskender, Nuran Ahu Baysal, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş. Evaluation of seasonal changes in the diagnosis of acute leukemia in Turkey. Medical Science and Discovery 2020; 7(5):501-4. Doi: 10.36472/msd.v7i5.38.

68. Gulsen Iskender, Sabahat Ceken, Mustafa Cihat Ogan, Omur Kayıkcı, Habıp Gedik, Emre Tekgunduz, Fevzi Altuntas, Mustafa Ertek. Hepatitis B virus reactivation in patients with hematological malignancies under lamivudine prophylaxis. Acta Medica Mediterranea 2019;5:2417. Doi: 10.19193/0393-6384_2019_5_377.

69. Merdin A, İskender D, Ulu BU, Doğan M, Çakar MK, Dal MS, Altuntaş F. Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment. Medicine (Baltimore). 2019 Jul;98(30):e16482. doi: 10.1097/MD.0000000000016482.

70. Duygu Mert, Sabahat Çeken, Gulsen Iskender, Dicle Iskender, Merdin Alparslan, Fazilet Duygu, Mustafa Ertek, Fevzi Altuntas. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. J Infect Dev Ctries 2019;13 (8):727-735. doi: 10.3855/jidc.11457.

71. Ciftciler R, Gökmen Sevindik Ö, Tekgündüz AİE, Erkurt MA, Vural F, Turgut B, Kaynar L, Payzın B, Doğu MH, Karakuş V, Altuntaş F, Buyukasık Y, Demirkan F. Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study. Turk J Haematol. 2019 May 27. doi: 10.4274/tjh.galenos.2019.2019.0008.

72. Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial. Lancet Oncol. 2019 May 13. pii: S1470-2045(19)30152-4. doi: 10.1016/S1470-2045(19)30152-4.

73. Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, Dogu MH, Gulturk E, Ulas T, Payzin B, Kuku I, Cagirgan S, Altuntas F. The Turkish experience with therapeutic plasma exchange: A national survey. Transfus Apher Sci. 2019 Apr 23. pii: S1473-0502(19)30064-3. doi: 10.1016/j.transci.2019.04.015.

74. Namdaroğlu S, İskender D, Dal MS, Çakar MK, Tekgunduz E, Altuntaş F. Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease. Hong Kong J Dermatol Venereol 2019; 27:12-18

75. Kaya AH, Tekgündüz E, Akpınar S, Bozdağ G, Yiğenoğlu TN, Merdin A, Namdaroğlu S, Kayıkçı Ö, Altuntaş F. Assessment of Ovarian Reserve with anti-Mullerian Hormone in Women Following Allogeneic Hematopoietic Cell Transplantation. Clinical and Experimental Obstetrics Gynecology, 2019:46(1):127-130.

76. Çalışkan EG, Şen K, Merdin A, Dal S, Altuntas F. Illness perception of the patients with hematological cancers: A single center study. International Journal of Pharma and Bio Sciences May 2019:10(2). DOI: 10.22376/ijpbs.2019.10.2.b204-210.

77. Çakar MK, Tekgündüz E, Dal MS, Merdin A, Başçı S, İskender D, Uğur B, Bekdemir F, Yıldız J, Ulu BU, Bakırtaş M, Yiğenoğlu TN, Batgi H, Kaya AH, İskender D, Altuntaş F. The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma. J Oncol Pharm Pract. 2019 Apr 2:1078155219841110. doi: 10.1177/1078155219841110.

78. Namdaroglu S, Kaya AH, Batgi H, Kayikci O, Dal MS, Iskender D, Kizil Cakar M, Tekgunduz E, Altuntas F. Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Sci Rep. 2019 Feb 14;9(1):2046.

79. Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 Feb 8;378(6):518-528.

80. Kaya AH, Namdaroğlu S, Kayıkcı Ö, Merdin A, Batgi H, İskender D, Dal MS, Kızıl Çakar M, Tekgunduz E, Altuntas F. Impact of Guideline-Driven Approach in Follow-Up of Long-Term Complications After Allogeneic Hematopoietic Cell Transplant: Single Center Experience. Exp Clin Transplant. 2018 Sep 25. doi: 10.6002/ect.2018.0007.

81. Altuntas F. Message from the incoming WAA president. Transfus Apher Sci. 2018 May 18. pii: S1473-0502(18)30170-8. doi: 10.1016/j.transci.2018.05.002.

82. Sabahat Çeken, Gulsen Iskender, Habip Gedik, Fazilet Duygu, Duygu Mert, Ali Hakan Kaya, Fevzi Altuntas, Mustafa Ertek. Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients. J Infect Dev Ctries 12 (4):265-272. doi: 10.3855/jidc.9720.

83. Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study. Transfus Apher Sci. 2018 Feb 20. pii: S1473-0502(18)30046-6. doi: 10.1016/j.transci.2018.02.012.

84. Dogu MH, Batgi H, Erkurt MA, Hacioglu S, Tekgunduz E, Kaya E, Iskender D, Eren R, Kuku I, Altuntas F. Stem cell mobilization kinetics in elderly patients with multiple myeloma. Transfus Apher Sci. 2018 Feb 1. pii: S1473-0502(18)30018-1. doi: 10.1016/j.transci.2018.01.010.

85. Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678.

86. Kaya AH, Tekgündüz E, Ilkkiliç K, Dal MS, Merdin A, Karakus A, Hacioglu SK, Bekdemir F, Çakar MK, Dogu MH, Ayyildiz MO, Korkmaz S, Altuntaş F. Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy. J Chemother. 2018 Feb;30(1):44-48.

87. Sevindik OG, Korkmaz S, Altuntas F. Current status of art mobilization in Myeloma. Transfus Apher Sci. 2017 Dec;56(6):850-853.

88. Fevzi Altuntaş, Serdal Korkmaz. Hematopoietic progenitor cell mobilization. Transfus Apher Sci. 2017 Dec;56(6):787.

89. Ömür Kayıkçı, EmreTekgündüz, Ali Hakan Kaya, Hakan Göker, Alma Aslan, Dicle İskender, Sinem Namdaroglu, Aysegul Tetik, Şerife Koçubaba, Fevzi Altuntaş. Biosimilar filgrastim (leucostim®️) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®️) and lenograstim (granocyte®️): A retrospective multicenter study. Transfus Apher Sci. 2017 Dec;56(6):832-835.

90. Namdaroglu S, Korkmaz S, Altuntas F. Management of mobilization failure in 2017. Transfus Apher Sci. 2017 Dec;56(6):836-844.

91. Mehmet Hilmi Dogu, Seçkin Çagirgan, Serkan Ocakci, Ali Hakan Kaya, Kadir Ilkkilic, Neslihan Mandaci Sanli, Selda Kahraman, Rafet Eren, Emre Tekgunduz, Sibel Hacioglu, Leylagul Kaynar, Mehmet Ali Erkurt, Fevzi Altuntas. Autologous Stem Cell Transplantation and Stem Cell Mobilization Kinetics in Elderly Patients with B Cell Non-Hodgkin Lymphoma. Transfus Apher Sci. 2017 Dec;56(6):814-818

92. Serdal Korkmaz, Fevzi Altuntas. What is the role of biosimilar G-CSF agents in hematopoietic stem cell mobilization at present? Transfus Apher Sci. 2017 Dec;56(6):795-799.

93. Emre Tekgündüz, Mutlu Arat, Hakan Göker, Hakan Özdoğu, Leylagül Kaynar, Seçkin Çağırgan, Mehmet Ali Erkurt, Filiz Vural, İlhami Kiki, Fevzi Altuntaş, Fatih Demirkan, on behalf of Turkish Society of Apheresis (TSA). Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: a position-statement from the Turkish society of apheresıs (TSA). Transfus Apher Sci. 2017 Dec;56(6):845-849.

94. Emre Tekgündüz, Fatih Demirkan, Filiz Vural, Hakan Göker, Hakan Özdoğu, İlhami Kiki, İsmet Aydoğdu, Leylagül Kaynar, Mehmet Ali Erkurt, Seçkin Çağırgan, Sevgi Beşışık, Simten Dağdaş, Ebru Koca, Gürhan Kadıköylü, Eren Gündüz, Mehmet Yılmaz, Hüseyin Beköz, Ali Uğur Ural, Fevzi Altuntaş. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Transfus Apher Sci. 2017 Dec;56(6):804-808.

95. Kaya AH, Tekgunduz E, Akpinar S, Batgi H, Bekdemir F, Kayikci O, Namdaroglu S, Ulu BU, Dal MS, Cakar MK, Korkmaz S, Altuntas F. Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting? Transplant Proc. 2017 Oct;49(8):1911-1915.

96. Gemici A, Aydogdu I, Terzi H, Sencan M, Aslan A, Kaya AH, Dal MS, Akay MO, Dogu MH, Ayyildiz O, Sahin F, Cagliyan GA, Yilmaz M, Gokgoz Z, Bilen Y, Demir C, Sevindik OG, Korkmaz S, Eser B, Altuntas F. Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematol Oncol. 2017 Jul 14. doi: 10.1002/hon.2460.

97. Duygu Mert, Hikmetullah Batgi, Alparslan Merdin, Sabahat Çeken, Mehmet Sinan Dal, Emre Tekgündüz, Fevzi Altuntaş, Mustafa Ertek. BK virus-associated hemorrhagıc cystitis in patients wıth allogeneıc hematopoıetıc cell transplantation: report of three cases. Hematology Reports 2017;9(2):76-77. DOI: https://doi.org/10.4081/hr.2017.7205.

98. Mert D, Iskender G, Duygu F, Merdin A, Dal Mehmet S, Dogan M, Tekgündüz E, Ertek M, Altuntaş F. Invasive Aspergillosis with Disseminated Skin Involvement in a Patient with Acute Myeloid Leukemia: A Rare Case. Hematol Rep. 2017 Jun 1;9(2):6997.

99. Merdin A, Yıldız J, Dal MS, Kızıl Çakar M, Kaya AH, Tekgündüz E, Altuntaş F. Coexistence of chronic lymphocytic leukemia and multiple myeloma, do the roots of these entities originate from the same place? Clin Case Rep. 2017 Apr 12;5(6):1032-1033.

100. Merdin A, Yıldız J, Dal Mehmet S, Çakar MK, Batgi H, Tekgündüz E, Onursever A, Altuntaş F.A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia.Hematol Rep. 2017 Mar 22;9(1):6995.

101. Ali Hakan Kaya, Emre Tekgündüz, Fazilet Duygu, Dicle İskender, Filiz Bekdemir, Hikmetullah Batgi, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Fevzi Altuntas. Risk adapted management of febrile neutrepenia in hematopoietic stem cell transplantation setting: Is it time for early cessation of empirical antibiotherapy? Balkan Med J 2017;34:132-9.

102. Mehmet Sinan Dal, Emre Tekgündüz, Merih Kızıl Çakar, Ali Hakan Kaya, Sinem Namdaroğu, Hikmetullah Batgi, Filiz Bekdemir, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Ali Kılınç, Dicle İskender, Bilge Uğur, Şerife Koçubaba, Gülşen İskender, Fevzi Altuntas. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?. Transfus Apher Sci. 2016 Aug;55(1):125-8.

103. Emre Tekgündüz, İsmail Sarı, Arif Kapuağası, Doğan Ünal, İrfan Şencan, Fevzi Altuntaş. Apheresis Training In Turkey. Transfus Apher Sci. 2016 Apr;54(2):173-5.

104. Mehmet Sinan Dal, Abdullah Karakuş, Merih Kızıl Çakar, Bahar Uncu Ulu, Elif Hattapoğlu, Mehmet Önder Ekmen, Turgay Ulaş, Emre Tekgündüz, Fevzi Altuntaş, Orhan Ayyıldız. Does the eltrompobag treatment safe or effective for refractory chronic immune thrombocytopenia patients? Int J Clin Exp Med 2016;9(9):18707-18711.

105. Tekgündüz, Emre, Ali Hakan Kaya, and Fevzi Altuntaş. "What Is the Optimal Consolidation Strategy for Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients in First Complete Remission if You Are Not Able to Look for Minimal Residual Disease?."International Journal of Hematology Research 2.2 (2016): 130-135.

106. Fatih Kurnaz, Cem Sahin, Leylagul Kaynar, Cigdem Pala, Serdar Sivgin, Fevzi Altuntas, Bulent Eser, Mustafa Cetin, Ali Unal. Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation. JBUON 2016; 21(1): 227-234.

107. Namdaroğlu S, Tekgunduz E, Altuntas F. Coexistence of essential thrombocythemia, iron-refractory iron deficiency anemia and renal cell carcinoma. Hematol Rep. Mar 18;8(1):6235. doi: 10.4081/hr.2016.6235.

108. Emre Tekgündüz, Hakan Göker, Leylagül Kaynar, İsmail Sarı, Çiğdem Pala, Mehmet Hilmi Doğu, Erman Öztürk, Burhan Turgut, Serdal Korkmaz, Ayşegül Tetik, Yahya Büyükaşık, Sibel Kabukçu Hacıoğlu, Sinem Civriz Bozdağ, Evren Özdemir, Fevzi Altuntaş. Adult Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience. Clin Lymphoma Myeloma Leuk. 2016 May;16(5):269-74.

109. Altuntas F. Brief Biography: Prof. Dr. Fevzi Altuntaş. Transfus Apher Sci. 2016 Apr;54(2):176. doi: 10.1016/j.transci.2016.04.003.

110. Emre Tekgündüz, İsmail Sarı, Fevzi Altuntaş. Guest editorial. Transfus Apher Sci September 2015. DOI: http://dx.doi.org/10.1016/j.transci.2016.01.005.

111. Emre Tekgündüz, İrfan Şencan, Arif Kapuağası, Doğan Ünal, Murat Öztürk, Hakan Göker, Emine Betül Tavil, Mehmet Ertem, Mustafa Çetin, Mutlu Arat, Teoman Soysal, Osman Karakaşlı, Halil Yılmaz Sur, Akif Yeşilipek, Burhan Ferhanoğlu, Duygu Uçkan, Osman İlhan, Fevzi Altuntas. Hematopoietic Cell Transplantation Activity In Turkey 2014: Ongoing Increase In HCT Rates. Transfus Apher Sci 2016 Feb;54(1):53-9.

112. Hayriye Dilek Yalvaç, Zeynep Kotan, Emre Tekgündüz, Ali Çayköylü, Fevzi Altuntaş. Could psychiatric assessment before hematopoietic stem cell transplantation predict the need for psychiatric consultation during transplantation period? Transfus Apher Sci. 2016 Feb;54(1):85-90.

113. Emre Tekgündüz, Leylagül Kaynar, Hakan Göker, Ali Hakan Kaya, Esra Ermiş Turak, Gürsel Güneş, Ömür Kayıkçı, Mustafa Çetin, Yahya Büyükaşık, Fevzi Altuntaş. Retrospective Analysis Of Adult Patients With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: A Multicenter Experience Of Daily Practice. Transfus Apher Sci 2016 Feb;54(1):41-7.

114. Emre Tekgündüz, Ali Hakan Kaya, Sinem Civriz Bozdağ, Şerife Koçubaba, Ömür Kayıkçı, Sinem Namdaroğlu, Bilge Uğur, Seval Akpınar, Hikmetullah Batgi, Filiz Bekdemir, Fusun Ozdemirkıran, Fevzi Altuntaş. Does Defibrotide Prophylaxis Decrease The Risk Of Acute Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation? Transfus Apher Sci 2016 Feb;54(1):30-4.

115. Mehmet Ali Erkurt, Ilhami Berber, Emre Tekgunduz, Mehmet Hilmi Dogu, Serdal Kormaz, Cengiz Demır, Mehmet Yılmaz, Olga Meltem Akay, Ciğdem Pala, Yusuf Bılen, Emin Kaya, Ismail Sarı, Mehmet Sencan, Irfan Kuku, Fevzi Altuntas, Sinan Dal, Ismet Aydogdu. Primary Central Nervous System Lymphoma In Daily Practice and The Role Of Autologous Stem Cell Transplantation In Relapsed Disease: A Retrospective Multicenter Study. Transfus Apher Sci. 2016 Feb;54(1):80-4.

116. Mehmet Hilmi Dogu, Ali Hakan Kaya, Ilhami Berber, Ismail Sarı, Emre Tekgunduz, Mehmet Ali Erkurt, Dicle Iskender, Omur Kayıkcı, Irfan Kuku, Emin Kaya, Ali Keskın, Fevzi Altuntas. Does The Preference Of Peripheral Versus Central Venous Access In Peripheral Blood Stem Cell Collection/Yield Change Stem Cell Kinetics In Autologous Stem Cell Transplantation? Transfus Apher Sci. 2016 Feb;54(1):76-9.

117. Khamid Karimov, Emre Tekgündüz, Alonur Saidov, Ömür Kayıkçı, Kodirzhon Boboev, Şerife Koçubaba, Abdurakhmon Kayumov, Ali Kılınç, Gülşen Adıbelli, Abdumannon Isroilov, Tuğçe Nur Türközü, Halil Yılmaz Sur, Nurullah Zengin, Fevzi Altuntaş. First Hematopoietic Cell Transplantation In Uzbekistan: Progress Through Education And Cooperation. Transfus Apher Sci. 2016 Feb;54(1):60-2.

118. Sinem Civriz Bozdag, Emre Tekgunduz, and Fevzi Altuntas. Treatment of acute graft versus host disease with mesancyhmal stem cells: questions and answers. Transfus Apher Sci. 2016 Feb;54(1):71-5.

119. Berber I, Erkurt MA, Keklik M, Dogu MH, Terzi H, Pala C, Sarı HI, Sencan M, Sıvgın S, Hacıoglu S, Altuntas F, Aydogdu, Ilhan O. Clinical characteristics, post-treatment assessment and prognostic factors affecting patient survival of patients at 65 years of age or older with hodgkin lymphoma: A retrospective multicenter study from Turkey. Acta Medica Mediterranea Sep 2015; 31(6):907-914.

120. Onur Esbah, Emre Tekgündüz, Itır Şirinoğlu Demiriz, Sinem Cıvrız Bozdağ, Ali Kaya, Ayşegül Teti, Ömür Kayıkcı, Gamze Durgun, Şerife Kocubaba, Fevzi Altuntaş. Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of Beam and High Dose ICE. Turk J Hematol 2015;32-1-14.doi: 10.4274/tjh.2014.0214.

121. Sinem Civriz Bozdag, Emre Tekgunduz, and Fevzi Altuntas. The Current Status in Hematopoietic Stem Cell Mobilization. J Clin Apher. 2015 Mar 19. doi: 10.1002/jca.21374.

122. Türker K, Albayrak M, Oksüzoğlu B, Balc E, Oğan MC, Iskender G, Altuntaş F. Entecavir as a first-line treatment for hepatitis B virus reactivation following polychemotherapy for chronic lymphocytic leukemia and invasive ductal carcinoma: a report of two cases and review of the literature. Eur J Gastroenterol Hepatol 2015;27 (1):39-45.

123. Punzel M, Korukluoğlu G, Caglayik DY, Menemenlioglu D, Bozdag SC, Tekgündüz E, Altuntaş F, Campos Rde M, Burde B, Günther S, Tappe D, Cadar D, Schmidt-Chanasit J. Dengue virus transmission by blood stem cell donor after travel to sri lanka; Germany, 2013. Emerg Infect Dis. 2014 Aug;20(8):1366-9.

124. Altuntas F, et al. International survey on apheresis. J Clin Apher 2014 (Report of an international survey on apheresis by the ASFA international affairs committee).

125. Demiriz IŞ, Tekgündüz E, Bozdağ SC, Altuntaş F. Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma. Turk J Hematol 2014;31:92-94.

126. Bozdag SC, Namdaroglu S, Kayikci O, Kaygusuz G, Demiriz I, Cinarsoy M, Tekgunduz E, Altuntas F. Diagnosis of large granular lymphocytic leukemia in a patient previously treated for acute myeloblastic leukemia. Hematol Rep. 2013 Dec 23;5(4):e14.

127. Unal A, Altuntaş F. Editorial. Transfus Apher Sci 2013;48 (3):291.

128. Itır Şirinoğlu Demiriz, Emre Tekgündüz, Sinem Civriz Bozdağ, Fevzi Altuntaş. How to be succesful in hematopoietic stem cell mobilization. Bone Marrow Research 2013.

129. Sinem Namdaroğlu, Emre Tekgündüz, Sinem Civriz Bozdağ, Gamze Durgun, Abdurrahman Sarıca, Itır Şirinoğlu Demiriz, Şerife Koçubaba, Gülşen İskender, Ömür Kayıkçı, Fevzi Altuntaş. Microbial contamination of hematopoietic progenitor cell products. Transfus Apher Sci 2013;48 (3): 403-406.

130. Sinem Civriz Bozdağ, Emre Tekgündüz, Gamze Durgun, Abdurrahman Sarıca, Itır Şirinoğlu Demiriz, Şerife Koçubaba, Fevzi Altuntaş. Which regimen is better for stem cell mobilization of lymphoma patients? Transfus Apher Sci. 2013;48 (3): 407-410.

131. Itır Şirinoğlu Demiriz, Sinem Civriz Bozdağ, Emre Tekgündüz, Bilge Uğur, Gamze Durgun, Şerife Koçubaba, Fevzi Altuntaş. Predicting the successful peripheral blood stem cell harvesting. Transfus Apher Sci 2013;48 (3): 411-414.

132. Oztürkmen S, Altuntaş F, Olcay L. Granulocyte transfusion therapy in paediatric patients with severe neutropenic infection. Transfus Apher Sci. 2013 ;48 (3): 381-5.

133. Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I, Erkurt MA, Sivgin S, Korkmaz S, Okan V, Doğu MH, Unal A, Cetin M, Altuntaş F, Ilhan O.Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis. Transfus Apher Sci. 2013;48 (3):349-52.

134. Korkmaz S, Keklik M, Sivgin S, Yildirim R, Tombak A, Kaya ME, Acik DY, Esen R, Hacioglu SK, Sencan M, Kiki I, Tiftik EN, Kuku I, Okan V, Yilmaz M, Demir C, Sari I, Altuntas F, Unal A, Ilhan O. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study. Transfus Apher Sci. 2013 ;48 (3):353-8.

135. IS. Demiriz, E. Tekgunduz, A. Tetik, Ö. Kayikci, F. Altuntaş. Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: A case report. Transfus Apher Sci, 48(1),109-11, (2013).

136. IS. Demiriz, E. Tekgunduz, F. Altuntaş. What Is the Most Appropriate Source for Hematopoietic Stem Cell Transplantation? Peripheral Stem Cell/Bone Marrow/Cord Blood," Bone Marrow Research 2012;2012:834040. doi: 10.1155/2012/834040. Epub 2012 Sep 27.

137. E. Tekgündüz, F. Altuntaş, S. Şılgın, ZS. Akı, A. Dönmez, P. Topçuoğlu, R. Yıldırım, N.Baysal, E. Ayyıldız, MK. Yüksel, I.Sarı, M. Tombuloğlu, A. Ünal, O. İlhan. Plerixafor use in patients with previous mobilizaton failure: a multicenter experience. Transfus Apher Sci, 47(1),77-80, (2012).

138. F. Altuntaş, A. Unal, O. Ilhan. Turkish Apheresis Activity for 2011. Transfus Apher Sci, 47(1),57-8, (2012).

139. MK. Yüksel, E. Tekgündüz, C. Sönmez, P. Topcuoglu, A. Yurtcu, IS. Demiriz, A. Tetik, Ö. Kayıkçı, M. Cınarsoy, F. Altuntaş. A feasible shortcut for the mobilization outcome: steady state CD34 positive hematopoietic stem cells. Transfus Apher Sci, 47(1), 67-75, (2012).

140. N. Ciledag, K. Arda, BK. Arıbas, E. Tekgunduz, F. Altuntaş. The role of multidetector computed tomography in early diagnosis of invasive pulmonary aspergillosis in patients with febrile neutropenia undergoing hematopoietic stem cell transplantation. Turk J Hematol, 29, 28-33, (2012).

141. ŞH. Arslan, Ü. Üyetürk, E. Tekgündüz, SÇ. Irkkan, MK.Yüksel, IS. Demiriz, F. Altuntaş. Diffuse Large B–Cell Lymphoma Transformed From Primary Breast Mucosa Associated Lymphoid Tissue Lymphoma: A Case Report. Turk J Hematol, 29, 274-277 (2012).

142. Ü. Üyetürk, ŞH. Arslan, MK. Yüksel, F. Altuntaş. Paclitaxel Therapy And Immune Thrombocytopenic Purpura: Coincidence Or Association? Turk J Hematol, 28,151-2, (2011).

143. E. Tekgunduz, MK. Yuksel, C. Erbay, B. Aribas, C. Ozdilekcan, H. Arslan, . Kocubaba, I. Demiriz, A. Tetik, K. Arda, F. Altuntaş. Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: Single Centre Experience. Oncology, 79(5-6), 409-414, (2010).

144. C. Saatci, AO. Caglayan, I. Kocyigit, H. Akalin, LG. Kaynar, F. Altuntas, B. Eser, M. Demir, M. Cetin, Y. Ozkul. Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma? Hematology, 15(1), 39-42 (2010).

145. S. Hacioglu, F. Altuntaş, L. Kaynar, I. Sarı, T. Patıroglu, M. Cetin. Rhabdomyolysis in a Healthy Peripheral Blood Stem Cell Donor Following the Mobilization with Filgrastim. Transfus Med Hemother, 36(2), 135-137, (2009).

146. S. Gokahmetoglu, L. Kaynar, F. Altuntaş, O. Yildiz, M. Cetin, I. Kocyigit. Detection and quantification of cytomegalovirus in bone marrow transplant recipients by real time PCR and pp65 antigenemia. Saudi Med J, 29(11), 1673-75, (2008).

147. F. Altuntaş, K. Matevosyan, J. Burner, S. Yu-Min, R. Sarode. Higher Optical Density of an Antigen Assay Predicts Thrombosis in Patients with Heparin- Induced Thrombocytopenia. Eur J Haematol, 80(5), 429-35, (2008).

148. I. Sarı, F. Altuntaş, S. Hacioglu, I. Kocyigit, A. Sevinc, S. Sacar, K. Deniz, E. Alp, B. Eser, O. Yildiz, L. Kaynar, A. Unal, M. Cetin. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol, 83(4), 334-39, (2008).

149. L. Kaynar, F. Altuntaş, I. Aydogdu, B. Turgut, I. Kocyigit, SK. Hacıoglu, S. Ismailogulları, N. Turgut, MA. Erkurt, I. Sarı, M. Oztekin, M. Solmaz, B. Eser, AO. Ersoy, A. Unal, M. Cetin. Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study. Transfus Apher Sci, 38(2),109-115, (2008).

150. I. Sarı, A. Cetin, L. Kaynar, R. Saraymen, SK. Hacioglu, A. Ozturk, I. Kocyigit, F. Altuntaş, B. Eser. Disturbance of the Pro-oxidative/Antioxidative Balance in Allogeneic Peripheral Blood Stem Cell Transplantation. Ann Clin Lab Sci, 38(2), 120-25, (2008).

151. F. Altuntaş, I. Sarı, I. Kocyigit, L. Kaynar, S. Hacioglu, A. Ozturk, M. Oztekin, M. M. Solmaz, B. Eser, M. Cetin, A. Unal. Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators. Transfus Med Hemother, 35, 368-373, (2008).

152. I. Sarı, I. Kocyigit, F. Altuntaş, L. Kaynar, B. Eser. An Unusal Case of Acute Brucellosis Presented with Coombs-positive Autoimmune Hemolytic Anemia. Inter Med, 47(11),1043-1045, (2008).

153. F. Altuntaş, İ. Aydogdu, S. Kabukcu, İ. Kocyigit, K. Cikim, İ. Sarı, M. Ali Erkut, B. Eser, A. Ozturk, E. Kaya, M. Cetin, A. Keskin, A. Unal. “Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study” Transfus Apher Sci, 36 (1), 57-67, (2007).

154. F. Altuntaş, Kocyigit I, Ozturk A, Kaynar L, Sarı I, Oztekin M, Solmaz M, Eser B, Cetin M, Unal A. Comparison of the Fenwal Amicus and Fresenius Com.Tec Cell Separators for Autologous Peripheral Blood Progenitor Cell Collection. Transfus Apher Sci, 36 (2), 159-167, (2007).

155. I. Sarı, F. Altuntaş, I. Kocyigit, Y. Sisman, B. Eser, A. Unal, T. Fen, A. Ferahbas, A. Ozturk, A. Unal, M. Cetin. The effect of budesonide mouthwash on oral chronic graft versus host disease. Am J Hematol, 82 (5), 349-356, (2007).

156. F. Altuntaş, İ. Sarı, Ö. Canoz, B. Eser, O. Yıldız, M. Çetin, A.Ünal. “Kikuchi-Fujimoto disease: A rare but important cause of fever and lymphadenopathy in pregnant women”. Am J Hematol, 81(2), 118–120, (2006).

157. B. Eser, F. Altuntaş, Ö. Er, O. Kontas, M. Cetin, A. Unal. “Acute Lymphoblastic Leukemia Associated with Brucellosis in Two Patients with Fever and Pancytopenia”. Yonsei Med J, 47(5), 741-744, (2006).

158. B. Eser, I. Sarı, Ö. Canöz, F. Altuntaş, E. Cakmak, A. Ozturk, M. Ozkan, Ö. Er, M. Cetin, A. Unal. “Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma”. Am J Hematol, 81(5), 307–314, (2006).

159. B. Eser, B. Kaplan, A. Unal, Ö. Canoz, F. Altuntaş, İ. Sarı, M. Cetin. “Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin’s Iymphomas in Central Anatolia, in Turkey”. Yonsei Medical Journal, 47(1), 22-33, (2006).

160. R. Sarode, F. Altuntaş. “Blood bank issues associated with red cell exchanges in sickle cell disease”, J Clin Apher, 21(4), 271-273, (2006).

161. Er O, Ozkan M, Altınbas M, Coskun HS, Eser B, F. Altuntaş, Cetin M, Unal A. Outpatient 5-Fluorouracil + Interferon alfa + Interleukin-2 Chemoimmunotherapy in Metastatic Renal Cell cancer Patients. Asia Pacific J Clin Oncol, 1, 145-150, (2005).

162. M. Cetin, S. Buyukberber, M. Demir, İ. Sarı, K. Deniz, B. Eser, F. Altuntaş, C. Camci, A. Ozturk, B. Turgut, O. Vural, A. Unal. “Overexpression of Cyclooxygenase-2 in Multiple Myeloma: Associated with Reduced Survival”. Am J Hematol, 80, 169-173, (2005).

163. F. Altuntaş, O. Yildiz, İ. Sarı, B. Eser, M. Cetin, A. Unal. “Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura”. Am J Haematol, 80, 204-205, (2005).

164. C. Kucuk, E. Sozuer, E. Ok, F. Altuntaş, Z. Yilmaz. “Laparoscopic versus open splenectomy in the management of benign and malign hematologic diseases: a ten-year single-center experience”. J Laparoendosc Adv Surg Tech A, 15(2),135-139, (2005).

165. HS. Coskun, Ö. Er, S. Soyuer, M. Altinbas, B. Eser, E. Karahacioglu, F. Altuntaş. “Solitary plasmacytoma: experiences from Central Anatolia”. Ir J Med Sci, 174(1), 33-36, (2005).

166. B. Eser, M. Guven, A. Unal, R. Coskun, F. Altuntaş, M. Sungur, IS. Serin, İ. Sari, M. Cetin. “The Role of Plasma Exchange in HELLP Syndrome”. Clin Appl Thromb Hemost, 11 (2), 211-217, (2005).

167. F. Altuntaş, O. Yıldız, B. Eser, İ. Sarı, M. Cetin, A. Unal. “Severe Thrombotic Microangiopathy Associated with Brucellosis: Successful Treatment with Plasmapheresis”. Clin Appl Thromb Hemost, 11(1),105-108, (2005).

168. F. Altuntaş, O. Yildiz, B. Eser, K. Gündogan, B. Sumerkan, M. Çetin. “Catheter-Related Bacteremia Due to Kocuria Rosea in a Patient Undergoing Peripheral Blood Stem Cell Transplantation”. BMC Infectious Diseases, 4, 62, (2004).

169. B. Barker, F. Altuntaş, G. Paranjape, R. Sarode. “Presurgical Plasma Exchange is Ineffective in Correcting Amyloid Associated Factor X Deficiency”. J Clin Apheresis, 19(4), 208-210, (2004).

170. S. Yazar, O. Yaman, B. Eser, F. Altuntaş, F. Kurnaz, I. Sahin. “Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia”. J Med Microbiol, 53, 1183-1186, (2004).

171. M. Ozkan, B. Eser, O. Er, F. Altuntaş, R. Coskun, R. Topsakal, E. Mavili, M. Kala, M. Altinbas. “Antiphospholipid syndrome associated with malignant mesothelioma presenting with superior vena cava thrombosis: a case report”. Clin Appl Thromb Hemost, 10(4), 393-396, (2004).

172. B. Eser, F. Altuntaş, O. Er, O. Kontas, A. Ferahbas, M. Cetin, A. Unal. “A case of subcutaneous panniculitis-like T-cell lymphoma with haemophagocytosis developing secondary to chemotherapy”. J Eur Acad Dermatol Venereol, 18(6), 713-715, (2004).

173. M. Guven, M. Sungur, B. Eser, I. Sarı, F. Altuntaş. “The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning”. J Toxicol Clin Toxicol, 42(5), 613-619, (2004).

174. O. Er, HS. Coskun, M. Altinbas, M. Ozkan, B. Eser, M. Cetin, F. Altuntaş, A. Unal. “Meropenem +/- granulocyte colony stimulating factor in the treatment of febrile neutropenic patients with cancer: prospective randomized study”. J Chemother, 16(3), 288-92, (2004).

175. S. Gullu, F. Altuntaş, I. Dincer, C. Erol, N. Kamel. “Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction”. Eur J Endocrinol, 150(5), 655-661, (2004).

176. S. Yazar, F. Altuntaş, I. Şahin, M. Atambay. “Dysentery caused by Balantidium coli in a patient with non-Hodgkin’s Iymphoma from Turkey”. World J Gastroenterol, 10(3), 458-459, (2004).

177. H. Akbulut, F. Altuntaş, KG. Akbulut, G. Ozturk, M. Cindoruk, E. Unal, F. Icli. “Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma”. Cytokine, 20(4), 184-190, (2002).

178. K. Keven, SJ. Bengisun, F. Altuntaş, H. Akar, G. Nergizoglu, K. Sim, N. Duman, B. Erbay. “Cystic infection of the liver in a maintenance haemodialysis patient”. Nephrol Dial Transplant, 16(4), 859-860, (2001).

179. Diğer: ...